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embryo cell line with varying melanin content
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Ottawa Regional Cancer Centre, 190 Melrose Avenue, Ottawa, Ontario, KJ Y 4K7, Canada.
Repair of radiation damage as well as cellular and environ-
mental factors can play a major role in radiosensitivity (Hall,
1978; Steel et al., 1983; Freeman et al., 1981). Both repair of
sublethal damage and potentially lethal damage have been
shown to increase cellular resistance to radiation (Elkind &
Sutton, 1960; Philips & Tolmach, 1966; Little, 1969). The
factors that influence radiosensitivity may play an important
role in the treatment of tumour cells by radiotherapy. It is
well known that some tumours such as osteosarcoma,
glioma and melanoma are difficult to control by radio-
therapy and may be radioresistant (Habermalz & Fischer,
1976; Nilsson et al., 1980; Abe et al., 1979). Some earlier
studies indicate that this resistance may be linked to the
ability of cells to repair radiation damage (Weichselbaum
et al., 1982; Weichselbaum & Little, 1983; Hahn & Little,
1972).
It was reported that melanoma was radioresistant and that
survival curves demonstrated a large shoulder (Barranco et
al., 1971; Smith et al., 1978; Trott et al., 1981). Several other
reports indicated that melanomas responded better to
fractionated radiotherapy if large fractions were given
indicating a large SLD repair capacity. However, there is
some debate regarding these findings (Hornsey, 1978;
Overgaard, 1980; Trott et al., 1981).
In vitro studies of melanoma have been conducted with
human cells and in such studies the normal parental cell
strain was not available for comparison. In our laboratory,
we have developed a melanoma-like cell line by trans-
formation of the C3H-lOT1/2 mouse embryo cell line
developed by Reznikoff et al. (1973). This cell line (R25)
possessed increased radioresistance in the survival curve
shoulder region, produced melanin and contained melano-
somes (Szekely et al., 1985). This cell line could be com-
pared directly to its parental strain since it was readily
available, whereas this is not possible with melanoma
tumour derived cell lines.
The R25 cell line has been studied to address several
questions arising from observations made in the study of
melanoma tumours and melanoma cell lines. (1) Does the
increased size of the survival curve shoulder indicate an
increased capacity for radiation damage repair? (2) Does the
presence of melanin influence radiosensitivity and heat
sensitivity? (3) Is this melanoma cell line sensitive in its
response to anti-melanoma chemical agents compared to its
normal parental cell line and other transformants not
exhibiting melanoma like properties.
The transformants were produced from the normal C3H-
IOTI/2 cells by radiation or H-ras oncogene transfection.
The culture conditions, and transformation procedures have
been previously described in detail (Raaphorst et al., 1985;
1987). Cells were cultured in a mixture of 1:1 Dulbecco's
modified MEM and F12 medium containing 10% foetal calf
serum. Details of cell culture, radiation procedures and
experimental manipulation have been previously described
(Raaphorst et al., 1985).
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Figure 1 shows the radiation survival responses of the
normal and three transformed cell lines. These cell lines were
grown in exponential growth phase and irradiated 16h after
plating the number of cells required to assess survival by
counting 50-150 viable colonies. In all other experiments
described, the radiation heat or drug treatments were given
after overnight incubation (16-18h). After 7-10 day
incubation the resulting colonies were stained and counted.
R25 represents the radiation transformed melanoma cell line
and R19 and Ciras 1 represent other transformed lines
produced by radiation and H-ras oncogene transfection,
respectively. The three transformed cell lines were not
contact inhibited, could grow in agarose and tended to
acidify the culture media more quickly than the normal cell
line. The survival curve parameters for these cell lines are as
follows: Normal a=0.39+0.05; ,=0.021 +0.008; n=2.0;
Do= 1.52. R25a=0.15 +0.06; ,B=0.045+0.009; n=6.0;
Do=1.31. The parameters for R19 and CIRAS are about
the same as for the normal cell line. To confirm results, each
experiment was repeated three times and 4-6 replicate flasks
were used per datum point in each experiment. One
representative experiment is shown and the error bars
indicate the standard error calculated from the 4-6 replicate
flasks. Survival curve parameters are calculated from
computerized least squares fitting and errors using methods
described by Freund (1967). These data show that the R25
survival curve has a larger shoulder than the other three
curves and this is reflected in the survival curve parameters.
The data presented in Table I indicate that the difference
in radiation reponse of R25 is probably not cell cycle
related. Cell cycle analysis (methods previously described,
Raaphorst et al., 1985) show that the normal and R25 cells
had about the same cell cycle distribution.
Figure lb shows that repair of sublethal damage was
greater in R25 than in the normal cell line in both
exponentially growing and plateau phase cells. Exponentially
growing and plateau phase cells were given split doses of
irradiation and incubated between doses at 37°C to allow
repair. The recovery ratios after 8 h were 6.2 and 3.4 or 4.6
and 2.6 for R25 and normal cells treated in plateau or
exponential growth phase, respectively. The higher recovery
in plateau phase cells indicates some repair of potentially
lethal damage (PLD) as well as sublethal damage (SLD).
The experiment in Figure lb was done using equal doses of
radiation instead of equal survival levels of the two cell lines.
Table I Cell cycle distribution
Cell cycle phases
Cell type GI S G2+M
Normal 52.2 25.7 22.1
R25 53.3 24.6 22.1
Data fitted by polynomial fitting algorithms supplied by Ortho.
Maximum error is <10%. Flow cytometry was done by isolating
nuclei and staining with ethidium bromide as previously described
(Raaphorst et al., 1985).
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Figure 1 (a) Radiation survival curves of normal C3H 1OT1/2 R19, CIRAS and R25 cells. The survival curve parameters are as
follows: Normal cx=0.39+0.05; P=0.021+0.008; n=2.0; Do=1.52; R25 oa=0.15+0.06; /=0.045+0.009; n=6.0; Do=1.31. The
parameter for R19 and CIRAS are about the same as for the normal line. (b) The repair of sublethal radiation damage in normal
(closed symbols) and R25 cells (open symbols) during incubation time at 37°C between two doses of radiation (indicated on
abscissa) for plateau phase cells (circles) and exponential phase cells (squares). (c) The growth curves and melanin content of normal
and R25 cells as a function of time in culture, 0 number of R25 cells per flask, 0 number of normal cells per flask, * melanin
content of R25 cells and EO melanin content of normal cells. (d) Radiation and heat response of R25 cells isolated from spheroids
with low (white), medium (brown) or high (black) melanin content. The parameters of the solid line on the radiation survival curve
are cx =0.19+ 0.037; ,B=0.063+0.009; n = 5.0; Do= 1.19. The dashed curve represents response of normal cells from a monolayer.
Table II Melanin content and response to 2 or 4 hydroxyanisole
Presence Percent survival
of
Cell line melanin PE 4HA (6 x 10-4M) 2HA (3 x 1O-3M)
C3H 1OTI/2 - 33+3% 41+3% 41+3%
R19 - 26+3% 43+3% 42+3%
Ciras - 21+3% 31+3% 34+3%
R25 + 48+3% 3.5+1% 9+1%
4HA, 4 hydroxyanisole; 2HA, 2 hydroxyanisole; PE, plating effici-
ency; Melanin was assayed as previously described (Szekely et al.,
1985). HA treatment was given after overnight incubation.
At isosurvival levels a higher dose would be necessary for
R25 possibly showing a greater degree of recovery.
Further tests were done to determine the nature of R25.
Table II and Figure Ic show that R25 produced melanin
while the normal and other transformed cell lines did not.
The method for melanin analysis has been described in detail
previously (Szekely et al., 1985). The melanin content of R25
cells increased as a function of incubation time in culture as
shown in Figure Ic. Electron microscopy studies indicated
the presence of melanosomes in these cells (Szekely et al.,
1985).
The data in Table II show that R25 cells exhibited a
greater response to 4-hydroxyanisole (4HA) and 2-
hydroxyanisole (2HA) treatment than normal and the other
X-ray transformed tumorigenic cell line R19 and the H-ras
transfected tumorigenic cell line Ciras 1. Cells were exposed
for 2h to the 4HA and 2HA dissolved in culture medium.
The latter two transformed cell lines exhibited the same
response to 4-hydroxyanisole as the normal cell line. The
increased response of R25 to 4HA and 2HA is similar to
that of melanin producing melanoma tumours and cells
(Riley, 1984; Meyskens, 1984). These data further indicate
the melanoma nature of R25.
Figure Id shows the heat and radiation response of R25
cells with various melanin content. When R25 cells were
seeded into a 0.34% agarose medium they formed
multicellular spheroids. In these cultures, spheroids of white,
brown and black morphology developed after 10 to 16 weeks
of growth. The number of spheroids that developed high
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melanin content was dependent on the cell density and
culture age and confirm the results of Weininger et al.
(1978). Cells were obtained from black, brown and white
spheroids of R25 selected from culture after 10-14 weeks of
incubation. Cells from these spheroids were isolated by
trypsinization, assessed for melanin content, plated into
flasks and tested for heat or radiosensitivity 16h after
plating: The responses to hyperthermia at 45°C and to
radiation were the same for cells from the three types of
spheroids. Also, no differences were observed for heating at
43.0°C (data not shown). Analysis of melanin content in the
cells isolated from the black, brown and white spheroids
indicated that cells from the black and brown spheroids
contained 2-8 fold more melanin than cells from the white
spheroids. Electron microscopy study showed that cells from
dark appearing spheroids contained high concentrations of
melanosomes (Szekely et al., 1985).
Two studies showed that the addition of exogenous
melanin in CHO cells or the variation of melanin content in
B16 melanoma cells did not influence radiation sensitivity
(Hopwood et al., 1985; Stephens et al., 1986). Our results on
R25 confirm this finding and further indicate that melanin
content over the range found in the white, brown and black
spheroids also did not influence thermal sensitivity.
However, the possibility cannot be ruled out that the range
of melanin content studied was saturating for possible
radiation effects down to the lowest level. For hyperthermia
effects this possibility could be ruled out because the
response of the normal cell line containing no melanin was
about the same as that for R25.
Our data clearly indicate that the transformation of C3H-
10T1/2 cells to R25 (melanoma like cell line) occurred
concomitantly with an increase in the survival curve shoulder
and an increased capacity to repair SLD compared to its
progenitor. In addition, this cell line produced melanin and
was sensitive to anti-melanin compounds while the other
transformed cell lines were not. In a previous study it was
shown that transformation led to random changes in radio-
sensitivity, primarily reflected in the survival curve Do
(Raaphorst et al., 1985). In R25, these changes were quite
different in that radioresistance was reflected in the survival
curve shoulder, typical of many human melanoma cell lines.
This melanoma cell line and its normal progenitor cell line
are being further investigated for differential responses to
anti-melanin agents since these are already in use in the
clinic (Webster et al., 1984; Morgan, 1984). These cell lines
make a good system for the comparison of melanoma and
normal cell responses to anti-cancer agents and treatments.
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